rFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia A
Condition(s):Hemophilia A With InhibitorLast Updated:February 1, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Hemophilia A With InhibitorLast Updated:February 1, 2024Completed
Condition(s):Hemophilia A With InhibitorLast Updated:March 26, 2014Completed
Condition(s):Hemophilia A With InhibitorsLast Updated:March 2, 2020Completed
Condition(s):Hemophilia A With InhibitorLast Updated:February 21, 2023Terminated
Condition(s):Hemophilia A With InhibitorsLast Updated:January 30, 2018Withdrawn
Condition(s):Hemophilia ALast Updated:March 29, 2018Approved for marketing
Condition(s):HaemophiliaLast Updated:December 18, 2015Unknown status
Condition(s):Hemophilia A With InhibitorLast Updated:May 11, 2021Completed
Condition(s):Severe Hemophilia A With InhibitorLast Updated:June 17, 2013Unknown status
Condition(s):Hemophilia A With InhibitorLast Updated:January 12, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.